‘Twincretin’ Weight Loss Scales Up Cardiometabolic Gains
A post hoc analysis of the SRMOUNT-1 study finds weight loss from the use of tirzepatide was associated with strong benefits in measures of cardiometabolic health. Medscape Medical News
Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study
Abstract Aims This cross-sectional study examined associations between self-reported taste perception changes and appetite-related outcomes in individuals with obesity treated with glucagon-like peptide-1 receptor agonist (GLP-1 RAS) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAS in real-world conditions. Materials and Methods Four hundred and eleven adults on Wegovy® (n = 217), Ozempic® (n = 148) and Mounjaro® (n = 46) completed an […]
Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence
Abstract Globally, cardiovascular diseases (CVDs) account for around one-third of all deaths. Clinical trial evidence suggests that treatment of people with obesity or type 2 diabetes (T2D) and CVD with glucagon-like peptide-1 (GLP-1) receptor agonists reduces the risk of major adverse cardiovascular events, heart failure outcomes and all-cause mortality. Tirzepatide is a once-weekly, dual glucose-dependent […]
LifeMD: An Overlooked GLP-1 Beneficiary
Post Content
These are the top 10 emerging technologies of 2025, according to the World Economic Forum
Breakthroughs happen all the time in the tech world, but only a select few manage to make a lasting impact. Predicting which innovations will shape the future is always a challenge. On Tuesday, the World Economic Forum (WEF) released its list of the top 10 emerging technologies of 2025, highlighting those expected to influence global […]
GLP-1 Agonists: Uses, Mechanism, and Side Effects
https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists The provided text from the Cleveland Clinic offers a comprehensive overview of GLP-1 agonists, a class of medications primarily used to manage Type 2 diabetes and obesity. It explains how these injectable drugs mimic a natural hormone to regulate blood sugar, slow digestion, and increase feelings of fullness, leading to potential weight loss. The source lists various approved GLP-1 agonists and their typical administration frequencies, […]
Semaglutide Shows Benefits for PAD Across T2D Subgroups
A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 diabetes, but more research is needed in those without diabetes. Medscape Medical News
Studies exploring muscle loss from GLP-1 drugs
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat, experts say.
‘Ozempic Penis’: Males Are Reporting a Surprising New GLP-1 Side Effect
A growing number of males on Reddit are claiming that GLP-1 drugs have increased their penis size. Kupicoo/Getty Images Male Reddit users are reporting what they call “Ozempic penis,” with some claiming penile growth of up to 1.5 inches. Experts say, however, that Ozempic penis is not a true side effect of GLP-1 drugs. Instead, […]
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs – Gizmodo
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs Gizmodo Hims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal Yahoo Finance HIMS BREAKING NEWS: Hims & Hers Health, Inc. is being Investigated for Securities Fraud; Investors with Losses are Notified to Contact BFA Law Business Wire Novo Nordisk ends collaboration with […]